Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Justin M Drake

Showing results (31-40 of 59) with videos related to

Pageof 6
Sort By:
Biorxiv : the Preprint Server for Biology|August 14, 2023
Unraveling the Global Proteome and Phosphoproteome of Prostate Cancer Patient-Derived XenograftsZoi E Sychev, Abderrahman Day, Hannah E Bergom, et al.
Molecular Cancer Research : MCR|February 12, 2024
Unraveling the Global Proteome and Phosphoproteome of Prostate Cancer Patient-Derived XenograftsZoi E Sychev, Abderrahman Day, Hannah E Bergom, et al.
Clinical Proteomics|July 12, 2026
Targeted proteomics for the detection of androgen receptor variants in preclinical models of castration-resistant prostate cancerZoi E Sychev, Gabrianne Larson, Megan L Ludwig, et al.
NPJ Precision Oncology|November 3, 2022
Integrative molecular analyses define correlates of high B7-H3 expression in metastatic castrate-resistant prostate cancerXiaolei Shi, Abderrahman Day, Hannah E Bergom, et al.
Biorxiv : the Preprint Server for Biology|August 6, 2025
Proteomic profiling of extracellular vesicles distinguishes prostate cancer molecular subtypesMegan L Ludwig, Ali T Arafa, Saasha Vinoo, et al.
Journal of Extracellular Vesicles|October 9, 2025
Proteomic Profiling of Extracellular Vesicles Distinguishes Prostate Cancer Molecular SubtypesMegan L Ludwig, Ali T Arafa, Saasha Vinoo, et al.
Endocrinology|December 7, 2025
A Plasma-based Deep Proteomic Platform for Early-Stage Breast Cancer DetectionAlec Horrmann, Yash Travadi, Kevin Mallery, et al.
Cell Reports. Medicine|June 7, 2021
Cabozantinib and dasatinib synergize to induce tumor regression in non-clear cell renal cell carcinomaHui-Wen Lue, Daniel S Derrick, Soumya Rao, et al.
Cancers|January 8, 2025
Isolation of Plasma Extracellular Vesicles for High-Depth Analysis of Proteomic Biomarkers in Metastatic Castration-Resistant Prostate Cancer PatientsAli T Arafa, Megan Ludwig, Onur Tuncer, et al.
NPJ Precision Oncology|September 30, 2024
Integrated multi-omics assessment of lineage plasticity in a prostate cancer patient with brain and dural metastasesMegan L Ludwig, David Moline, Alec Horrmann, et al.
Pageof 6

Showing results (31-40 of 59) with videos related to

Sort By:
Pageof 6
Biorxiv : the Preprint Server for Biology|August 14, 2023
Unraveling the Global Proteome and Phosphoproteome of Prostate Cancer Patient-Derived XenograftsZoi E Sychev, Abderrahman Day, Hannah E Bergom, et al.
Molecular Cancer Research : MCR|February 12, 2024
Unraveling the Global Proteome and Phosphoproteome of Prostate Cancer Patient-Derived XenograftsZoi E Sychev, Abderrahman Day, Hannah E Bergom, et al.
Clinical Proteomics|July 12, 2026
Targeted proteomics for the detection of androgen receptor variants in preclinical models of castration-resistant prostate cancerZoi E Sychev, Gabrianne Larson, Megan L Ludwig, et al.
NPJ Precision Oncology|November 3, 2022
Integrative molecular analyses define correlates of high B7-H3 expression in metastatic castrate-resistant prostate cancerXiaolei Shi, Abderrahman Day, Hannah E Bergom, et al.
Biorxiv : the Preprint Server for Biology|August 6, 2025
Proteomic profiling of extracellular vesicles distinguishes prostate cancer molecular subtypesMegan L Ludwig, Ali T Arafa, Saasha Vinoo, et al.
Journal of Extracellular Vesicles|October 9, 2025
Proteomic Profiling of Extracellular Vesicles Distinguishes Prostate Cancer Molecular SubtypesMegan L Ludwig, Ali T Arafa, Saasha Vinoo, et al.
Endocrinology|December 7, 2025
A Plasma-based Deep Proteomic Platform for Early-Stage Breast Cancer DetectionAlec Horrmann, Yash Travadi, Kevin Mallery, et al.
Cell Reports. Medicine|June 7, 2021
Cabozantinib and dasatinib synergize to induce tumor regression in non-clear cell renal cell carcinomaHui-Wen Lue, Daniel S Derrick, Soumya Rao, et al.
Cancers|January 8, 2025
Isolation of Plasma Extracellular Vesicles for High-Depth Analysis of Proteomic Biomarkers in Metastatic Castration-Resistant Prostate Cancer PatientsAli T Arafa, Megan Ludwig, Onur Tuncer, et al.
NPJ Precision Oncology|September 30, 2024
Integrated multi-omics assessment of lineage plasticity in a prostate cancer patient with brain and dural metastasesMegan L Ludwig, David Moline, Alec Horrmann, et al.
Pageof 6